- Evaluation of the GORE TAG Thoracic Endoprosthesis--45 mm for the Primary Treatment of Aneurysms of the Descending Thoracic Aorta
Have you been diagnosed with a Thoracic Aortic Aneurysm?
Doctors at Massachusetts General Hospital are participating in a clinical research trial studying the safety and effectiveness of the 45 mm Gore TAG device in subjects with aneurysms of the descending thoracic aorta. This treatment is an alternative to open surgical repair for thoracic aortic aneurysms. If you have questions about this research study or are interested in participating, you should contact Dr. Richard Cambria, the Principal Investigator or Tara Bresnahan, the Research Coordinator. We are available to provide you with further information regarding this study. Please call 617-643-2731 or e-mail tbresnahan2@partners.org.
Institution- MGH- Massachusetts General Hospital
Principal Investigator- Richard Cambria, MD
Enrollment Information
For further information about enrolling a patient in this research trial, contact the person below.
Name- Tara Bresnahan
Email- tbresnahan2@partners.org
Phone-617-643-2731
Doctors at Massachusetts General Hospital are participating in a clinical research trial studying the safety and effectiveness of the 45 mm Gore TAG device in subjects with aneurysms of the descending thoracic aorta. This treatment is an alternative to open surgical repair for thoracic aortic aneurysms. If you have questions about this research study or are interested in participating, you should contact Dr. Richard Cambria, the Principal Investigator or Tara Bresnahan, the Research Coordinator. We are available to provide you with further information regarding this study. Please call 617-643-2731 or e-mail tbresnahan2@partners.org.
Institution- MGH- Massachusetts General Hospital
Principal Investigator- Richard Cambria, MD
Enrollment Information
For further information about enrolling a patient in this research trial, contact the person below.
Name- Tara Bresnahan
Email- tbresnahan2@partners.org
Phone-617-643-2731
Institution – MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator – Richard Cambria, MD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name – Tara Bresnahan, CRC
Email – tbresnahan2@partners.org
Phone – 617-643-2731
